Heal Squad' podcast host Maria Menounos, whose pancreatic cancer was discovered early enough to be treated, says, "If it ...

The Quest AD-Detect® blood-based test panels deliver confirmatory accuracy, potentially supporting reduced reliance on ...

Quest’s two AD-Detect blood-based tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer’s disease pathology in ...

Quest Diagnostics Incorporated shows post-pandemic growth with Q3 results, strategic expansion, and steady returns. Click for ...

Maria Menounos, a cancer survivor, has partnered with Exact Sciences to promote Cancerguard, a groundbreaking blood test that can detect over 50 types of cancer.

Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...

GRAIL's financial position is reinforced by $435 million in new funding, including strategic backing from Samsung for ...

Guardant Health received FDA approval for its Guardant360 CDx blood test as a companion diagnostic for Eli Lilly’s Inluriyo, targeting advanced breast cancer patients with ESR1 mutations. This ...

The complications highlight pregnancy as a crucial life opportunity for CV health optimization, said investigators led by ...

WHOOP Advanced Labs sits inside the WHOOP ecosystem as an optional labs add-on that pairs 65 blood biomarkers with your 24/7 ...

While Quest Diagnostics raised its revenue and adjusted earnings guidance for full-year 2025, the company lowered its GAAP ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...